CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+124.13%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.64B
AUM Growth
+$1.64B
(+62%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
13.82%
Top 10 Holdings %
Top 10 Hldgs %
56.65%
Holding
43
New
13
Increased
12
Reduced
8
Closed
8
Top Buys
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$82.3M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$67.1M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$63.2M |
| 4 |
ARQL
Arqule Inc
ARQL
|
$54M |
| 5 |
Exact Sciences
EXAS
|
$53.6M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$96.9M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
$94.9M |
| 3 |
Globus Medical
GMED
|
$67.1M |
| 4 |
Vericel Corp
VCEL
|
$36.3M |
| 5 |
uniQure
QURE
|
$35.8M |
Sector Composition
| 1 | Healthcare | 93.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Aurinia Pharmaceuticals
AUPH
$1.58B
| $134M | 8.19% | 6,625,671 +4,064,402 | +159% | +$82.3M |
|
|
ARQL
2
DELISTED
Arqule Inc
ARQL
| $134M | 8.18% | 6,715,965 +2,704,623 | +67% | +$54M |
|
3
Karyopharm Therapeutics
KPTI
$61.7M
| $117M | 7.17% | 6,127,434 +290,000 | +5% | +$5.56M |
|
|
EPZM
4
DELISTED
Epizyme, Inc
EPZM
| $106M | 6.47% | 4,306,575 +331,521 | +8% | +$8.16M |
|
5
United Therapeutics
UTHR
$13.8B
| $81M | 4.94% | 919,263 -48,306 | -5% | -$4.25M |
|
|
CCXI
6
DELISTED
ChemoCentryx, Inc.
CCXI
| $75.2M | 4.59% | 1,901,667 +235,000 | +14% | +$9.29M |
|
7
Align Technology
ALGN
$10.3B
| $75.1M | 4.58% | 269,000 -30,000 | -10% | -$8.37M |
|
|
KDMN
8
DELISTED
Kadmon Holdings, Inc.
KDMN
| $70.9M | 4.32% | 15,642,064 +4,948,490 | +46% | +$22.4M |
|
|
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $67.8M | 4.14% | 1,975,000 +1,955,000 | +9,775% | +$67.1M |
|
|
10
uniQure
QURE
$896M
| $66.6M | 4.06% | 929,036 -499,166 | -35% | -$35.8M |
|
|
GWPH
11
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $63.2M | 3.86% | +604,604 | New | +$63.2M |
|
|
12
Exact Sciences
EXAS
$8.98B
| $53.6M | 3.27% | +579,666 | New | +$53.6M |
|
13
Axogen
AXGN
$743M
| $53.4M | 3.26% | +2,986,386 | New | +$53.4M |
|
14
Sarepta Therapeutics
SRPT
$1.78B
| $46M | 2.8% | 356,145 +344,145 | +2,868% | +$44.4M |
|
15
CareDx
CDNA
$727M
| $45.8M | 2.79% | 2,121,976 +1,395,848 | +192% | +$30.1M |
|
16
Omeros
OMER
$283M
| $45M | 2.75% | 3,195,796 +364,687 | +13% | +$5.14M |
|
17
Iovance Biotherapeutics
IOVA
$807M
| $41.8M | 2.55% | 1,509,327 -170,000 | -10% | -$4.71M |
|
|
OXFD
18
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $39.2M | 2.39% | 2,363,724 +219,200 | +10% | +$3.64M |
|
19
Assembly Biosciences
ASMB
$190M
| $38.4M | 2.35% | +1,878,395 | New | +$38.4M |
|
20
Travere Therapeutics
TVTX
$1.56B
| $32.9M | 2.01% | 2,314,421 | – | – |
|
21
Tandem Diabetes Care
TNDM
$845M
| $32.8M | 2% | 550,956 -471,301 | -46% | -$28.1M |
|
|
ISEE
22
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $29.4M | 1.79% | +3,426,365 | New | +$29.4M |
|
|
LMNL
23
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
| $27.5M | 1.68% | +3,287,311 | New | +$27.5M |
|
|
24
Vericel Corp
VCEL
$1.83B
| $27.1M | 1.65% | 1,556,137 -2,088,355 | -57% | -$36.3M |
|
|
APTO
25
DELISTED
Aptose Biosciences, Inc.
APTO
| $27.1M | 1.65% | +4,772,190 | New | +$27.1M |
|